Clinical trial
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic…
NCT00031980 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00031980 |
|---|---|
| Title | Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer |
| Official title | Phase II Study of Cyclosporine in T-Cell Large Granular Lymphocytic Leukemia |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Leukemia, Neutropenia, Thrombocytopenia |
| Intervention type | Drug |
| Interventions | cyclosporine |
| Enrollment | 30 |
| Start date | Mar 1, 2002 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 6, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: